Thymus cancer
Showing 1 - 25 of >10,000
Thymoma, Thymus Tumors Trial run by the NCI (Sunitinib)
Active, not recruiting
- Thymoma
- Thymus Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 17, 2022
NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)
Completed
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Augusta, GeorgiaAugusta University Georgia Cancer Center
Jun 10, 2022
Thyroid Cancer Trial in Hangzhou (Resection based on "thymus-vascular-inferior parathyroid" complex)
Not yet recruiting
- Thyroid Cancer
- Resection based on "thymus-vascular-inferior parathyroid" complex
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital Zhejiang University School of Medicin
Feb 24, 2023
Thymic Carcinoma Trial in Shanghai (Envolizumab combined with radiotherapy)
Recruiting
- Thymic Carcinoma
- Envolizumab combined with radiotherapy
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Sep 3, 2023
Molecular Analysis of Thoracic Malignancies
Enrolling by invitation
- Thymus Cancer
- +5 more
-
Stanford, CaliforniaStanford University School of Medicine
Jun 8, 2021
Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)
Not yet recruiting
- Neuroendocrine Tumors
- +2 more
-
Bourdeaux, France
- +24 more
Jun 23, 2023
Thymic Epithelial Tumor, Recurrent Thymoma, Thymic Cancer Trial run by the NCI (PT-112)
Recruiting
- Thymic Epithelial Tumor
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Molecular Analysis and Treatment Options of Thymic Malignancies
Recruiting
- Thymic Epithelial Tumor
- +2 more
-
Shanghai, Shanghai, ChinaXiaomin Niu
Dec 28, 2022
Rapid Autopsy and Procurement of Cancer Tissue
Recruiting
- Thymus Tumors
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Thymoma, Thymic Cancer Trial in Houston (Pembrolizumab)
Recruiting
- Stage III Thymoma AJCC v8
- +6 more
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Esophageal Tumors, Lung Tumors, Mesothelioma Trial run by the NCI (Mithramycin)
Terminated
- Esophageal Neoplasms
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Mar 10, 2022
Recurrent Malignant Thymoma, Thymoma Trial in Houston (Diaphragm Fluoroscopy, Magnetic Resonance Imaging)
Active, not recruiting
- Recurrent Malignant Thymoma
- Thymoma
- Diaphragm Fluoroscopy
- Magnetic Resonance Imaging
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)
Completed
- Pancreas Cancer
- +6 more
-
Rozzano, Milan, ItalyIstituto Clinico Humanitas
Sep 9, 2022
Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2
Recruiting
- Thyroid Cancer, Medullary
- +3 more
-
Basel, SwitzerlandUniversity Hospital Basel, Clinic for radiology and nuclear medi
May 23, 2022
Cardiac MRI Biomarker Testing (GCC 1618)
Recruiting
- Breast Cancer
- +4 more
- Complete Cardiac Magnetic Resonance Imaging (MRI)
-
Baltimore, MarylandUmmc Msgccc
Aug 16, 2021
Neuroendocrine Tumors, Carcinoma, Small Cell Lung, Neuroendocrine Carcinoma Trial in United Kingdom, United States (PEN-221)
Completed
- Neuroendocrine Tumors
- +2 more
-
Fort Myers, Florida
- +12 more
Nov 16, 2021
Thymoma and Thymic Carcinoma Trial in Guangzhou (Thymosin a1, hypofractionated radiotherapy, concurrent chemoradiotherapy)
Active, not recruiting
- Thymoma and Thymic Carcinoma
- Thymosin a1
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Nov 27, 2021
Thymoma, Thymic Carcinoma, Clinical Masaoka Stage II to IVA Trial in United States (Cetuximab, Cisplatin, Doxorubicin &
Active, not recruiting
- Thymoma
- +2 more
- Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide
-
Duarte, California
- +7 more
May 27, 2022
Thymoma Malignant Recurrent Trial in France (Radiotherapy, Surveillance after resection)
Recruiting
- Thymoma Malignant Recurrent
- Radiotherapy
- Surveillance after resection
-
Angers, France
- +17 more
Aug 8, 2022
Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States
Recruiting
- Pancreatic Cancer
- +49 more
-
Colorado Springs, Colorado
- +80 more
Feb 22, 2022
Advanced Digestive System Neuroendocrine Tumor, Duodenal Neuroendocrine Tumor G1, Functional Pancreatic Neuroendocrine Tumor
Completed
- Advanced Digestive System Neuroendocrine Neoplasm
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 8, 2020
Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)
Recruiting
- Type B3 Thymoma
- Thymic Carcinoma
-
Milan, ItalyNational Cancer Institute
Jun 8, 2021